Tag: FDA guidance 2025
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026
The FDA's 2025 guidance streamlines biosimilar approval by replacing costly clinical trials with advanced analytical data, accelerating access to lower-cost biologic alternatives for cancer, arthritis, and diabetes. Learn how the process works and what's still holding it back.
view morerecent posts
Learn how to track drug side effects with a symptom diary that helps doctors identify real reactions faster. Includes what to log, best tools, common mistakes, and when to seek help.
Published ON: 14 JanCombining SSRIs and NSAIDs significantly raises the risk of dangerous gastrointestinal bleeding. Learn why this common drug combo is risky, who’s most vulnerable, and what steps to take to stay safe - including safer pain relief options and when to use protective medication.
Published ON: 4 JanLearn how to safely dispose of unused opioids using take-back programs, deactivation pouches, or FDA-approved household methods to prevent misuse, accidental overdoses, and protect your family and community.
Published ON: 6 JanPCOS makes weight loss harder due to insulin resistance. Learn how diet, timing, and movement can break the cycle of fat storage, cravings, and hormonal imbalance-without extreme diets.
Published ON: 8 JanStatins reduce heart attack risk but can cause muscle damage when combined with certain drugs. Learn which statins and medications raise myopathy risk, how to spot symptoms, and safer alternatives.
Published ON: 11 Jan